Cell Biosciences, Inc. and Alpha Innotech Corp. have announced that they have entered into a definitive agreement providing for the acquisition of Alpha Innotech by Cell Biosciences for $1.50 per ...

Agreement fortifies firm’s protein-analysis offerings. Cell Biosciences is taking over Alpha Innotech for $17.9 million in cash. This acquisition expands the company’s protein-analysis business to ...

BROOMFIELD, Colo.--(BUSINESS WIRE)--Dec. 14, 2004--XTRANA, Inc. (OTCBB:XTRN) and Alpha Innotech Corporation announced today that they have entered into a definitive Agreement and Plan of Merger ...

Alpha Innotech Corporation has announced that it has entered into a non-exclusive supply and distribution agreement with GE Healthcare. Under the terms of the agreement, Alpha Innotech will bundle ...

Alpha Innotech Corp. said Thursday it has appointed Michael Henighan as its new chief financial officer and principal accounting officer. Prior to joining Alpha (OTCBB: APNO), which makes digital ...

SANTA CLARA, Calif., Oct. 28 Cell Biosciences, Inc. today announced that it has completed its acquisition of Alpha Innotech Corp. (OTC Bulletin Board: APNO). The stockholders of Alpha Innotech have ...

Cell Biosciences is buying Alpha Innotech for $1.50 per share, or about $17.9 million in cash. The acquisition expands Cell Biosciences' protein analysis business. "This strategic acquisition marks an ...

FluorChem CCD imaging of a western blot using a typical chemiluminescent substrate. In May of this year, Alpha Innotech Corp. of San Leandro, Calif., launched ChemiGlow, a luminol-based ...

applications. The company has sold over 10,000 systems worldwide. In 2008, Alpha Innotech achieved revenues of $17.6 million and was profitable on both an operating and a net income basis. Alpha ...

SANTA CLARA, Calif., Sept. 8 Cell Biosciences, Inc. and Alpha Innotech Corp. (OTC Bulletin Board: APNO) today announced that they have entered into a definitive agreement providing for the acquisition ...